Database Limitations
The database of regimens in DoseCalc OnLine was developed in 1993
and the software was issued in March 1994. Much like any printed
handbook or text of oncology regimens, the database of regimens may
become out-of-date over time since new regimens may have been
published and become generally-accepted after the DoseCalc database
was developed. In addition, regimens included in the DoseCalc database
may have subsequently been modified based on published results of
clinical trials. In using the DoseCalc OnLine software, then,
HEALTH-CARE PROFESSIONALS HAVE THE SOLE RESPONSIBILITY
TO BE FULLY AWARE OF CURRENT PRACTICES AND STANDARDS,
TO AVOID USE OF OUTDATED REGIMENS, TO EMPLOY GOOD
CLINICAL JUDGMENT IN SELECTING REGIMENS/CALCULATING
DOSES FOR INDIVIDUAL PATIENTS, AND TO VERIFY ALL DOSAGE
CALCULATIONS obtained through use of the DoseCalc OnLine software.
Computer software in general and DoseCalc OnLine in particular should
NEVER substitute for up-to-date personal knowledge and good clinical
judgment. Healthcare professionals with comments or questions about
DoseCalc OnLine should e-mail dosecalc@meds.com.
DoseCalc is a registered trademark of Glaxo Wellcome Inc., Research
Triangle Park, NC
©Copyright 1995, 1996, 1997 & 1998 Glaxo Wellcome, Inc.
Selling, distributing, publishing, circulating, or commercially exploiting
this electronic database and software program without the express written
permission of Glaxo Wellcome Inc. and UltiTech, Inc. is prohibited. Use of
the database and software shall not convey any ownership right, title or
interest, nor any security or other interest in any intellectual property rights
relating to the database and software nor in any copy of any part of the
database and software.